Norris Medicines Limited (BOM:524414)
16.34
+0.76 (4.88%)
At close: Aug 18, 2026
Norris Medicines Market Cap
Norris Medicines has a market cap or net worth of 155.81 million as of August 18, 2026. Its market cap has decreased by -9.73% in one year.
Market Cap
155.81M
Enterprise Value
370.95M
Revenue
75.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.34
ChartMarket Cap Chart
Since December 3, 2001, Norris Medicines's market cap has increased from 34.30M to 155.81M, an increase of 354.26%. That is a compound annual growth rate of 6.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 155.81M | -2.32% |
| Dec 31, 2025 | 159.51M | -8.07% |
| Dec 31, 2024 | 173.51M | 27.48% |
| Dec 29, 2023 | 136.11M | -1.95% |
| Dec 30, 2022 | 138.81M | 29.72% |
| Dec 31, 2021 | 107.01M | 72.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rekvina Laboratories | 224.72M |
| Hamps Bio | 213.44M |
| Colinz Laboratories | 201.20M |
| Add-Shop E-Retail | 189.41M |
| Zenith Healthcare | 166.05M |
| Desh Rakshak Aushdhalaya | 153.28M |
| Shamrock Industrial Company | 140.84M |
| Ortin Global | 124.25M |